{"title":"The biologic finance and access council 2nd annual biologics healthcare survey: views from key healthcare stakeholders, part 2.","authors":"David B Nash, Michael Toscani, F Randy Vogenberg","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Part 2 of BFAC's survey reveals a range of understanding among providers, purchasers, and payers about the management of biologics and the implications of their use.</p>","PeriodicalId":89534,"journal":{"name":"Biotechnology healthcare","volume":"8 3","pages":"23-5"},"PeriodicalIF":0.0000,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278121/pdf/bh0803023.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biotechnology healthcare","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Part 2 of BFAC's survey reveals a range of understanding among providers, purchasers, and payers about the management of biologics and the implications of their use.